sanofi pasteur — The vaccines business of sanofi-aventis Group
Protect
VaccinePlace.com -- Search. Know more. For US Residents Only

Home | About Us | Site Map
Privacy Policy
Legal Notice
Explore Protect Learn
Hib disease | Influenza disease | Meningococcal disease | Pertussis disease | Polio disease | Rabies disease | Adolescent Immunization  

[BACK]

How many doses of vaccine will you need this year?


Note: This Dosing Table may assist health-care professionals in determining the estimated number of doses needed. Please do not count any individual more than once, even if this individual fits multiple risk categories. Fluzone.com is not responsible for verifying the accuracy of dose totals or that these estimates will meet the specific needs of your practice in a given influenza season.

Pediatric dosage (0.25mL) for children 6 months to ≤ 3 years of age

Patient type Number in your practice
(enter estimated #)		 Percentage you
will immunize
(enter estimated %)		 Estimated number
of doses needed		 Special Notes
Children age 6 through 23 months old, never before immunized against influenza Recommended dosage: 0.25mL x 2 doses > 1 month apart
Children 10 through 23 months who were previously immunized against influenza (1 shot)
Children age 24 through 36 months old, with "high-risk conditions," never before immunized against influenza Recommended dosage: 0.25mL x 2 doses > 1 month apart
Children age 24 through 36 months old, with high-risk conditions, previously immunized against influenza  
Estimated total number of doses needed. Pediatric dose (0.25mL—available as preservative-free vaccine, in prefilled syringes):  

Adult Dosage

References: 1. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2005;54:1-44 2005-2006 recommendations 2. Fluzone Vaccine Prescribing Information, July 2005.

Indication
 Fluzone vaccine is indicated for active immunization in persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information
 The most common local and systemic adverse reactions to Fluzone vaccine include soreness, pain, and swelling at the vaccination site; fever, malaise, and myalgia. Other adverse reactions may occur. Influenza vaccine should not be administered to anyone with a history of hypersensitivity to any vaccine component, including eggs, egg products, or thimerosal (the only presentation that contains thimerosal is the multi-dose vial). Fluzone vaccine should not be administered to individuals who have a prior history of Guillain-Barré syndrome (GBS). Vaccination with Fluzone vaccine may not protect all individuals.
 
Before administering Fluzone vaccine, please see accompanying full Prescribing Information.

[BACK]
Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 13-Aug-2010